Strawberry

Strawberry (Fragaria spp.): A Comprehensive Reference

1. Identity, Botanical Classification, and Common Forms

Botanical and Scientific Identity

Strawberry is a widely grown hybrid species of single-ovary fruit that is indehiscent, and the scientific name of the commercially dominant strawberry is Fragaria × ananassa, belonging to the family Rosaceae, which is native to the Americas, Europe, and Asia, and is cultivated worldwide for its fruits. The species designation × ananassa denotes its hybrid origin. The native range of Fragaria virginiana is North America, while Fragaria chiloensis is native to Chile; owing to its heart shape and red color, the fruit has been used as a symbol of Venus and the goddess of love. In the 18th century, the hybrid fruit originated in Europe and later was developed by most countries in the 19th century, being suitable across altitudes, climates, day lengths, and production types.

The wild strawberry, Fragaria vesca L. (woodland or Alpine strawberry), is also significant in traditional medicine and pharmacological research. Fragaria vesca, the wild strawberry, is a rich source of biologically active phenolic compounds such as tannins, anthocyanins, flavonoids, and phenolic acids. A further species, Fragaria viridis, occurs naturally in parts of Central Asia and Europe and has been studied for its phytochemical profile.

What is commonly called the strawberry "fruit" is, botanically speaking, an accessory fruit. Technically, what we call the strawberry fruit is actually an enlarged receptacle of the flower, with the true fruits being the small seeds (achenes) on the outside.

Common Forms and Preparations

Strawberry is produced commercially for immediate consumption as well as in processed forms such as canned, frozen, juice, and preserved berries. In research and supplementation contexts, freeze-dried (lyophilized) strawberry powder is the most commonly studied standardized form, as lyophilization preserves the polyphenolic content while enabling precise dosing. Other preparations encountered in research and traditional use include fresh whole fruit, dried fruit, leaf and root teas and decoctions, aqueous and ethanolic extracts, and standardized polyphenol concentrates isolating specific compounds such as anthocyanins, ellagic acid, or fisetin.

2. Traditional and Historical Use

Ancient Rome and Classical Antiquity

The ancient Romans believed that strawberry had great medicinal value; they used it to alleviate the symptoms of a wide array of maladies ranging from melancholy to kidney stones. Throughout antiquity, the strawberry saw many different uses other than as a food source. The Romans used strawberries to lift the spirits and relieve bad breath, as well as to treat a variety of digestive complaints.

Medieval Europe

The story of European strawberry cultivation stalls until the 1300s, when the French are credited with first bringing the wild strawberry from the forest to their gardens, propagating it by cutting off the runners. The French King Charles V (r. 1364–1380), for example, is said to have had 1,200 strawberry plants in his royal garden. In the early 1400s, western European monks were using the wild strawberry in their illuminated manuscripts, and, echoing the ancient Roman literature, the entire strawberry plant was being used medicinally to treat depressive illnesses.

Native American Traditions

Native Americans ate the berries fresh, dried them, and ground them into a pulp, which they mixed with cornmeal to make strawberry bread, a precursor to today's shortcake. They also brewed the leaves into a tea, which they believed had many medicinal uses, including blood purification. North American First Nation tribes used strawberries as medicine, particularly as a women's medicine used to clear toxins and support fertility and child-rearing. Due to their important medicinal and nutritional properties, strawberries are strongly tied to the cultural traditions of many Native American tribes. Humans have depended on the abundance of strawberries for hundreds of years, and more specifically, tribes in the Pacific Northwest continue to rely on this berry for their cultural identities.

Natives considered wild strawberries a sacred plant and a symbol of prosperity, as it is the first berry to appear in early summer. They also used the leaves in tea to treat scurvy and to soothe burns and sores.

Traditional Uses of Leaves and Roots

The root and leaves are a natural astringent and contain tannins, making them a strong digestive. The roots and leaves are most often used to treat diarrhea, dysentery, and other gastric issues such as bloating and cramps. Indigenous peoples of North America used the roots and leaves of wild strawberry plants for medicinal purposes, while in Europe, they were used in traditional remedies for fever and other ailments.

East Asian Traditional Use

In China, records of strawberry cultivation date back to the 14th century during the Ming dynasty. Strawberries were highly valued for their medicinal properties, particularly as a treatment for fever and digestive issues.

3. Key Constituents and Active Compounds

Phenolic Profile Overview

The phytochemical constituents of strawberry include gallotannins, ellagitannins, ellagic acid, anthocyanins, proanthocyanins, catechins, cyanidin, coumaroyl glycosides, pedunculagin, pelargonidin, flavonols, chlorogenic acid, salicylic acid, and caffeic acid, which have various medicinal properties including regulating heart function, antidiarrheal activity, antioxidant effects, diuretic action, blood pressure reduction, elevation of good cholesterol, and effects relevant to esophageal cancer.

Total phenolic content, calculated as the sum of individual compounds, varied 2.3-fold among 27 studied cultivars, ranging from 57 to 133 mg/100 g fresh weight. There were significant differences among cultivars in the concentration of all phenolic compounds. The concentration of anthocyanins—the most abundant class of phenolic compounds in the majority of cultivars—varied from 8.5 to 65.9 mg/100 g fresh weight. Flavan-3-ols (11–45 mg/100 g fw) and ellagitannins (7.7–18.2 mg/100 g fw) contributed on average 28% and 14% to total phenolic content in the strawberry cultivars, respectively.

Anthocyanins

The most important anthocyanins in strawberry are pelargonidin-3-glucoside, cyanidin-3-glucoside, pelargonidin-3-rutinoside, and pelargonidin-3-malonyl-glucoside, as well as ellagic acid and ellagitannins. Pelargonidin-3-glucoside is one of the main anthocyanin compounds, which is genetically independent. Clinical studies with healthy subjects having a single portion of 200–750 g of strawberries revealed a peak in anthocyanin metabolites in plasma between 2 and 3 hours after fruit consumption, with subsequent normalization within an additional 6-hour period.

Ellagitannins and Ellagic Acid

The amount of hydrolysable ellagitannins in strawberries, depending on origin and ripeness, may reach 637 mg/kg fresh weight on average. Ellagic acid is poorly absorbed and is also eliminated quickly from the body. These characteristics may limit its usefulness as a medicine in isolated form. Ellagitannins are hydrolyzed in the gastrointestinal tract to ellagic acid, which is subsequently metabolized by intestinal microbiota into urolithins—bioavailable phenolic metabolites that are believed to exert many of the downstream biological effects associated with ellagitannin-rich foods.

Flavonols: Quercetin, Kaempferol, and Fisetin

Strawberry also contains flavonols recognized as kaempferol and quercetin derivatives. Quercetin is a major bioactive constituent in Fragaria species and serves as a pharmacologically active ingredient in numerous therapeutic formulations. Among its most significant pharmacological properties are antioxidant, antidiabetic, and anticancer activities. Notably, strawberry is the richest known dietary source of fisetin (3,3′,4′,7-tetrahydroxyflavone), a flavonol with emerging research interest for its neuroprotective and senolytic properties.

Other Phenolic Acids and Vitamins

Strawberries contain phytochemicals with potent antioxidant and anti-inflammatory properties, such as anthocyanins, caffeic acid, ellagic acid, and flavonoids including tannins, catechin, quercetin, kaempferol, and gallic acid derivatives. They also contain vitamins C, E, and carotenoids. Among 15 identified compounds in strawberry pomace, quercetin-3-glucuronide, kaempferol-3-glucuronide, tiliroside, ellagic acid, malic acid, succinic acid, citric acid, and p-coumaric acid were among the most abundant constituents.

4. Established Mechanisms of Action

Antioxidant Activity

Polyphenols, especially anthocyanins, are known as powerful antioxidants. The mechanism of action of these compounds is multidirectional: free radical scavenging, chelation of transition metal ions (copper, iron), inhibition of enzymes involved in the formation of reactive oxygen species (ROS), induction of endogenous antioxidant enzymes, and prevention of lipid peroxidation.

Anti-Inflammatory Activity

Seeram et al. (2001) studied the inhibitory effects of strawberries on cyclooxygenase (COX) in vitro, a key enzyme that plays an important role in the conversion of arachidonic acid to various eicosanoids involved in inflammation. Anti-inflammatory, anticoagulant, vasodilatory, and antioxidant effects are some of the reported biological activities of Fragaria vesca constituents.

Lipid and Metabolic Pathways

Documented beneficial effects of strawberry include the reduction of atherosclerotic markers in subjects with metabolic syndrome, a decrease in LDL peroxidative damage, and augmentation of plasma antioxidant activity. These beneficial effects can be attributed to the presence of numerous phytochemicals, mostly polyphenols with antioxidant and anti-inflammatory properties.

Glucose Metabolism

Ellagic acid reduces pancreatic β-cell dysfunction and postprandial hyperglycemia. Hydroxycinnamic acids protect the endothelium from hyperglycemia-induced oxidative stress by lowering cell adhesion molecule (CAM) expression, and anthocyanins support glucose metabolism and β-cell survival via antioxidant-mediated regulation of apoptosis. In a dose-response study in individuals with obesity and insulin resistance, insulin and glucose responses after strawberry intake with a meal were associated with the main anthocyanin metabolite of strawberry, pelargonidin glucuronide.

Antithrombotic and Endothelial Effects

An in vitro experiment showed that 0.5–1 mg/mL strawberry extract decreased P-selectin and platelet aggregation, implying antithrombotic effects through suppression of inflammatory mediators.

Gut Microbiome Mediation

Almost all berry compounds must undergo microbial transformation before entering the body's circulatory system, making intestinal microbiota of paramount importance in mediating the health effects of strawberry bioactives.

5. Scientific Evidence by Area of Health Use

5.1 Cardiovascular Health

Evidence Summary: Moderate-strength evidence from multiple RCTs and meta-analyses, though individual results are mixed and effect sizes are modest.

A comprehensive systematic review and meta-analysis incorporating a total of 20 groups from 14 clinical trials found that the pooled effect size showed strawberry supplementation decreased circulating oxidized LDL (MD = −5.8 ng/mL; p = 0.012), malondialdehyde (0.309 µmol/L, p = 0.002), C-reactive protein (MD = −0.472 mg/L, p = 0.003), total cholesterol (MD = −6.49 mg/dL; p = 0.019), and diastolic blood pressure (MD = −2.220 mmHg, p = 0.033).

A separate meta-analysis published in the British Journal of Nutrition that included 11 RCTs reached a more conservative conclusion. Overall, the strawberry interventions significantly reduced CRP levels by 0.63 (95% CI −1.04, −0.22) mg/L but did not affect blood pressure, lipid profile, or fasting blood glucose in the main analyses. This discrepancy between meta-analyses may reflect differences in study selection criteria, population characteristics, and definitions of "strawberry supplementation."

At the individual trial level, in a study of subjects with metabolic syndrome, strawberry supplementation significantly decreased total and LDL-cholesterol (from 5.8 ± 0.2 to 5.2 ± 0.2 mmol/L, and 3.5 ± 0.2 to 3.1 ± 0.1 mmol/L, respectively; p < 0.05).

One rigorous randomized, controlled, double-blinded, 2-arm, 2-period crossover trial enrolled 34 adults (mean age 53 years; BMI 31 kg/m²; mean LDL cholesterol 133 mg/dL) who were randomly allocated to study sequences. Participants drank study beverages twice daily containing freeze-dried strawberry powder (2 × 25 g) or an energy- and volume-matched control powder for 4 weeks, separated by a 4-week washout.

In a study of freeze-dried strawberry powder in women with metabolic syndrome, the powder was used as a concentrated source of polyphenolic flavonoids, fiber, and phytosterols. Females (n = 16) with three features of metabolic syndrome were enrolled, and subjects consumed two cups of the strawberry drink daily for four weeks, each cup containing 25 g freeze-dried strawberry powder blended in water.

Limitations: Most trials are short (4–12 weeks), use small sample sizes, and rely on freeze-dried powder rather than fresh fruit. Results across meta-analyses are heterogeneous, suggesting population-specific and dose-specific effects.

5.2 Inflammation and Oxidative Stress

Evidence Summary: Consistent evidence from multiple clinical studies supporting reductions in CRP and oxidative biomarkers; considered one of the more robust areas of strawberry research.

Strawberries are a source of dietary polyphenols and vitamins. For these reasons, strawberries play an important beneficial role by improving antioxidant defenses against the development of several chronic diseases.

In a controlled, acute-response study with overweight men and women, whole-fruit strawberry powder containing 39 mg anthocyanins consumed with a high-carbohydrate, high-fat meal reduced plasma insulin and postprandial inflammatory markers including C-reactive protein and IL-6. These effects were associated with increased levels of anthocyanins and metabolites in postprandial plasma.

In a meta-analysis that included 13 randomized controlled trials with 488 participants, strawberry supplementation significantly reduced diastolic blood pressure, LDL cholesterol, and high-sensitivity C-reactive protein.

Strawberry pomace extracts possess strong antioxidant capacity in DPPH and ABTS radical scavenging and oxygen radical absorbance capacity (ORAC) assays.

5.3 Glucose Metabolism and Metabolic Syndrome

Evidence Summary: Preliminary-to-moderate human evidence, with some positive signals for postprandial insulin and glucose responses; evidence for chronic glycemic control is less consistent.

Reduced postprandial insulin (1–3 h) and attenuated postprandial inflammation have been shown to occur for up to 10 h in middle-aged, overweight and obese individuals consuming strawberries with a typical Western meal, and in a younger overweight group consuming strawberries 2 h before the meal.

While purified anthocyanins have improved HbA1c and insulin sensitivity in prediabetes, a meta-analysis found greater HbA1c reductions from fruit powder-derived anthocyanins, indicating synergistic actions among bioactive elements.

In at least one controlled trial of strawberry supplementation in overweight insulin-resistant middle-aged adults, there was no effect of the intervention on metabolic measures, possibly a consequence of the sample size, length of the intervention, or comparatively low anthocyanin dose.

There is emerging evidence on the role of strawberries in attenuating features of metabolic syndrome based on mechanistic and limited clinical trials. In vitro models have shown that specific strawberry cultivars significantly inhibit α-glucosidase activity and angiotensin-1-converting enzyme (ACE) activity.

Limitations: Most glycemic studies are acute or short-term. Longer-term RCTs in diabetic populations are needed to establish clinical significance.

5.4 Cancer Chemoprevention — Esophageal Precancerous Lesions

Evidence Summary: One noteworthy randomized phase II clinical trial with significant histological results; considered preliminary and requiring larger confirmatory trials.

Based on preclinical observations, researchers conducted a randomized (noncomparative) phase II trial in China to investigate the effects of two doses of freeze-dried strawberries in patients with esophageal dysplastic lesions in a high-risk area for esophageal cancer. They randomly assigned 75 patients identified by endoscopy to have dysplastic esophageal premalignant lesions to receive freeze-dried strawberry powder at either 30 g/day (37 patients) or 60 g/day (38 patients) for six months; the powder was mixed with water and drunk.

The dose of 60 g/day reduced the histologic grade of dysplastic premalignant lesions in 29 (80.6%) of the 36 patients at this dose who were evaluated for histology (p < 0.0001). The strawberry powder was well tolerated, with no toxic effects or serious adverse events.

Strawberries (60 g/day) also reduced protein expression levels of inducible nitric oxide synthase (iNOS) by 79.5% (p < 0.001), cyclooxygenase-2 (COX-2) by 62.9% (p < 0.001), phospho-NF-κB-p65 by 62.6% (p < 0.001), and phospho-S6 by 73.2% (p < 0.001). Freeze-dried strawberries also significantly inhibited the Ki-67 labeling index by 37.9% (p = 0.023).

The lead researcher concluded that "strawberries may be an alternative or work together with chemopreventive drugs in the prevention of esophageal cancer," while cautioning that these are preliminary data and that the findings need to be replicated in large, placebo-controlled randomized trials.

Recent data demonstrated that strawberry consumption led to the diminished progression of precancerous lesions and exerted chemoprevention in rodent tissues. Many observations suggest that the potential chemoprevention of berries (including strawberries) may be exerted via a variety of combinations of type and amount of bioactive compounds; their quality and synergism; and the level of fruit processing, type of diet, and intestinal microbiota.

Limitations: The esophageal trial was non-comparative (no placebo arm), conducted in a specific high-risk population in China, and has not been replicated at scale. The findings cannot yet be generalized to cancer prevention in general populations.

5.5 Cognitive Function and Neuroprotection

Evidence Summary: Emerging human evidence with early-phase RCTs showing modest cognitive benefits; preclinical evidence for fisetin is more extensive but human translation is unconfirmed.

Consumption of berry fruits, including strawberries, has been shown to influence metabolism as well as cognitive performance, suggesting potential to mitigate risk for dementia. In one controlled trial, researchers enrolled overweight middle-aged men and women with insulin resistance and subjective cognitive decline and performed a 12-week intervention with daily administration of whole-fruit strawberry powder.

Researchers observed diminished memory interference (p = 0.02; Cohen's f = 0.45) and a reduction of depressive symptoms (p = 0.04; Cohen's f = 0.39) for the strawberry-treated participants, benefits consistent with improved executive ability.

That study concludes that a 12-week intervention of daily whole-fruit strawberry powder can effectively reduce the risk of dementia in middle-aged individuals with subjective cognitive decline, evidenced by decreased memory interference and depressive symptoms.

In a 2021 study published in the British Journal of Nutrition, participants were given freeze-dried strawberries that contained about 50 milligrams of fisetin. After three months, they improved in some cognition aspects, including increased word recognition in the California Verbal Learning test.

Regarding fisetin specifically, researchers have noted that "companies have put fisetin into various health products but there hasn't been enough serious testing of the compound," and that "based on ongoing work, we think fisetin might be helpful as a preventative for many age-associated neurodegenerative diseases, not just Alzheimer's, and we'd like to encourage more rigorous study of it." Researchers fed the antioxidant fisetin to mice for seven months and found that the compound partially protected the animals from age-associated cognitive decline. Fisetin's effects correlated with the restoration of neuronal function and less brain inflammation. These results, however, are preclinical and should not be extrapolated directly to humans.

Limitations: Human cognitive trials are small, short-term, and focused on at-risk populations (overweight, insulin-resistant, older adults). Fisetin's cognitive effects in humans are poorly characterized. Animal and in vitro data predominate for neuroprotection claims.

5.6 Antioxidant Status in Vivo

Animal research has shown that a high-fat diet increased lipid and protein oxidation, and strawberry supplementation could reduce oxidative stress in the brain, which can be related to the antioxidant and anti-inflammatory effects of strawberry. Clinical studies with healthy subjects having a single portion of 200–750 g of strawberries revealed a peak in anthocyanin metabolites in plasma between 2 and 3 hours after fruit consumption, with subsequent normalization within an additional 6-hour period. These pharmacokinetic findings are consistent with antioxidant effects that are transient rather than sustained unless strawberry is consumed regularly.

5.7 Oral and Gastrointestinal Health

Evidence Summary: Traditional use is well-documented; clinical data are sparse.

The roots and leaves of strawberry are natural astringents containing tannins, making them a strong digestive agent. They are most often used in traditional herbalism to treat diarrhea, dysentery, and other gastric issues such as bloating and cramps. The same herbal infusion can be used as a mouthwash and gargle to treat gingivitis, inflammation, and ulcers, according to traditional use. These applications are rooted in historical use and in vitro data; there are no well-powered clinical trials specifically assessing these outcomes.

6. Body Systems Associated with Strawberry Research

• Cardiovascular system: Effects on LDL cholesterol, total cholesterol, diastolic blood pressure, CRP, oxidized LDL, endothelial function, and flow-mediated dilation.
• Metabolic/endocrine system: Postprandial insulin response, glucose metabolism, insulin sensitivity, and metabolic syndrome components.
• Gastrointestinal system: Traditional use for diarrhea, dysentery, digestive complaints; esophageal chemopreventive effects in clinical trials.
• Central nervous system / cognition: Memory, executive function, depressive symptom reduction; fisetin-mediated neuroprotection in animal models.
• Immune and inflammatory system: CRP reduction, COX inhibition, NF-κB pathway suppression, IL-6 modulation.
• Integumentary system: Traditional topical application; cosmetic research on F. vesca extract for antioxidant skin applications.
• Renal system: Traditional use for kidney stones and urinary conditions (Roman medicine), with limited contemporary evidence.

7. Dosage Forms and Reported Dosages in Research

The following dosages are reported as used in the cited studies and are not recommendations:

• Cardiovascular / metabolic syndrome studies (freeze-dried powder): Subjects consumed two cups of the strawberry drink daily for four weeks, each cup containing 25 g freeze-dried strawberry powder blended in water (total 50 g/day).
• Crossover cardiovascular trial: In a randomized, double-blinded, controlled, crossover trial, subjects consumed a strawberry beverage containing 25 g freeze-dried strawberry powder or an energy-matched control beverage twice a day for 4 weeks, with treatment periods separated by a 4-week washout period. (total 50 g/day).
• Esophageal cancer chemoprevention: Patients were randomly assigned to receive freeze-dried strawberry powder at either 30 g/day (37 patients) or 60 g/day (38 patients) for six months, mixed with water and drunk. The 60 g/day dose was associated with the significant reduction in dysplasia grade.
• Cognitive function trial (12-week): Overweight middle-aged men and women with insulin resistance and subjective cognitive decline received a 12-week intervention with daily administration of whole-fruit strawberry powder.
• Dose-response cardiovascular study: A proposed 3-period randomized crossover study used low-dose freeze-dried strawberry powder (13 g/day) and high-dose (40 g/day), each provided for 4–6 weeks and separated by a 2-week washout period. The 13 g/day low dose was described as equivalent to approximately 1 serving of fresh strawberries per day, representing a quantity easily achievable under free-living conditions.
• Fisetin-containing dose (cognition): In a published study, participants were given freeze-dried strawberries that contained about 50 mg of fisetin.

Due to the presence of a significant amount of biologically active substances and high nutritional value, strawberry pomace has great potential to be used as a source for health-beneficial ingredients for functional foods, nutraceuticals, cosmeceuticals, and other healthy natural products.

8. Safety Considerations and Interactions

General Tolerability

In the esophageal dysplasia clinical trial, strawberry powder (60 g/day for six months) was well tolerated, with no toxic effects or serious adverse events reported. A study specifically tested the tolerability and safety of freeze-dried strawberry powder in subjects with metabolic syndrome and found it to be safe in that population.

Allergic Reactions and Oral Allergy Syndrome

Raw strawberries contain allergens that cause oral allergic syndrome (OAS). Fra a 1 is one of the major allergens in strawberries and its allergenicity might decrease upon heating, likely due to structural changes in the allergen leading to decreased recognition in the oral cavity.

Strawberries contain an allergen associated with OAS, also known as pollen food allergy syndrome. OAS is an immediate-type allergy involving IgE antibody and is induced when IgE causes cross-reactivity with fruit and vegetable allergens that have a high degree of protein sequence identity with Bet v 1, a birch pollen allergen. Typical symptoms include buccal irritation, soreness, itching, and angioedema. Pathogenesis-related 10 (PR-10) proteins are major allergens involved in OAS, and in strawberries, Fra a 1, belonging to the PR-10 family, is one of the primary allergens causative of OAS.

White or yellow strawberry varieties often completely lack the Fra a 1 protein, and consequently do not produce the flavonoids that appear red in most mature strawberries. This observation has implications for individuals with OAS who may tolerate pale-fruited cultivars.

Some individuals have allergic reactions to strawberries. The most common is called oral allergy syndrome; however, allergic symptoms similar to those of hay fever are also prevalent. Skin problems such as dermatitis or hives can also occur, and in serious cases, breathing problems can develop.

Bioavailability Considerations for Ellagic Acid

Ellagic acid is poorly absorbed and is also eliminated quickly from the body. These characteristics may limit its usefulness as a concentrated medicine. Bioavailability is strongly influenced by gut microbiota composition, as ellagitannins must first be metabolized to ellagic acid and then further to urolithins; individuals vary substantially in their urolithin-producing microbiome capacity.

Interaction with Anticoagulant Agents

The safety of vitamin K antagonist use can be compromised by many popular herbal supplements. The literature reports that 30% of warfarin-treated patients self-medicate with herbs. Strawberry itself does not appear among the herbs with established major-severity interactions with warfarin in clinical evidence reviews — among 38 assessed herbs, cannabis, chamomile, cranberry, garlic, ginkgo, grapefruit, lycium, red clover, and St. John's wort were evaluated to have major severity interactions with warfarin — but the theoretical additive antiplatelet activity of strawberry phenolics (notably salicylic acid and platelet-aggregation-inhibiting compounds) warrants attention in patients on anticoagulant or antiplatelet therapies. An in vitro experiment showed that strawberry extract at 0.5–1 mg/mL decreased P-selectin and platelet aggregation, implying antithrombotic effects through suppression of inflammatory mediators.

Potential Interaction with Chemotherapy

Research on related berry compounds raises theoretical concerns in oncology contexts. Although dietary ellagic acid did not alter the tumor growth inhibition by docetaxel of xenografted cancer cells in one model, ellagic acid has the potential to interfere with taxane chemotherapy by reducing tubulin polymerization while inhibiting P-glycoprotein drug efflux — a finding from preclinical in vitro and animal research that has not been confirmed in human clinical trials but merits monitoring in patients on taxane-based regimens who consume large amounts of strawberry-derived ellagic acid.

Oxalate Content

Strawberries contain moderate levels of oxalic acid. While this has historically led to advice that individuals prone to calcium oxalate kidney stones limit high-oxalate foods, the clinical significance of strawberry intake specifically for this population has not been rigorously quantified in controlled trials.

Ripening Stage and Allergenic Protein Expression

Fra a 1 was found to be highly expressed in immature fruit, whereas Fra a 2 was expressed in young to ripe fruit. This differential expression may be relevant to the varying allergenic potential of strawberries at different ripeness stages.

References

• IntechOpen: Phytochemical Constituents and Pharmacological Activities of Strawberry
• PubMed: Phenolic compounds in strawberry (Fragaria x ananassa Duch.) fruits: Composition in 27 cultivars and changes during ripening
• PMC: A Review of Botany, Phytochemistry, and Biological Activities of Fragaria vesca and Fragaria viridis
• PubMed: The Content of Secondary Metabolites and Antioxidant Activity of Wild Strawberry Fruit (Fragaria vesca L.)
• PMC: Recovery of Bioactive Compounds from Strawberry (Fragaria × ananassa) Pomace
• PMC: Fragaria vesca L. Extract: A Promising Cosmetic Ingredient with Antioxidant Properties
• PMC: Strawberry Intake Ameliorates Oxidative Stress and Decreases GABA Levels Induced by High-Fat Diet in Frontal Cortex of Rats
• RSC Food & Function: Effects of strawberry supplementation on cardiovascular risk factors: a comprehensive systematic review and meta-analysis
• British Journal of Nutrition: Effects of strawberry intervention on cardiovascular risk factors: a meta-analysis of RCTs
• ScienceDirect / Journal of Nutrition: Strawberry Consumption, Cardiometabolic Risk Factors, and Vascular Function: A Randomized Controlled Trial
• PMC: Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome
• PMC: Effect of Strawberry Intake for 4 Weeks on Vascular Endothelial Function and Blood Pressure in Adults with Moderate Hypercholesterolemia
• PMC: Consumption of strawberries on a daily basis increases the non-urate DPPH radical scavenging activity of fasting plasma in healthy subjects
• PMC: Neuroprotective effects of berry fruits on neurodegenerative diseases
• PMC: Protective Effects of a Strawberry Ellagitannin-Rich Extract against Pro-Oxidative and Pro-Inflammatory Dysfunctions
• PMC: Protective Effects of Ellagitannin-Rich Strawberry Extracts in Rats Fed a Diet High in Fructose
• PMC: Antidiabetic, Lipid Normalizing, and Nephroprotective Actions of the Strawberry
• PMC: Early Intervention in Cognitive Aging with Strawberry Supplementation
• PMC: Comment on Krikorian et al. Early Intervention in Cognitive Aging with Strawberry Supplementation
• PMC: Dietary Strawberries Improve Biomarkers of Antioxidant Status and Endothelial Function in Adults with Cardiometabolic Risks
• PMC: Dietary Strawberries Improve Serum Antioxidant Profiles in Adults with Prediabetes: A 28-Week Randomized Controlled Crossover Trial
• PubMed: Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus
• AACR Cancer Prevention Research: Randomized Phase II Trial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus
• PMC: Chemoprevention of esophageal cancer with black raspberries, their component anthocyanins, and a major anthocyanin metabolite, protocatechuic acid
• PMC: Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome
• ClinicalTrials.gov: Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome (Protocol)
• PMC: Expression Profiling of Strawberry Allergen Fra a during Fruit Ripening Controlled by Exogenous Auxin
• ScienceDirect: Expression and purification of 15N-labeled Fra a 1, a strawberry allergen
• PMC: Interactions between Natural Health Products and Oral Anticoagulants: Spontaneous Reports in the Italian Surveillance System
• PMC: Updates on the Clinical Evidenced Herb-Warfarin Interactions
• PMC: Effects of Black Raspberries and Their Ellagic Acid and Anthocyanin Constituents on Taxane Chemotherapy
• PMC: Improved metabolic function and cognitive performance in middle-aged adults following a single dose of wild blueberry